Celltrion
068270.KS
#761
Rank
ยฃ21.43 B
Marketcap
ยฃ99.61
Share price
-0.28%
Change (1 day)
-6.77%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): ยฃ2.48

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ2.41. In 2022 the company made an earnings per share (EPS) of ยฃ2.35 a decrease over its 2021 EPS that were of ยฃ2.79.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ2.485.79%
2022ยฃ2.35-15.84%
2021ยฃ2.7912.77%
2020ยฃ2.4770.79%
2019ยฃ1.4515.63%
2018ยฃ1.25-33.13%
2017ยฃ1.87141.17%
2016ยฃ0.788.28%
2015ยฃ0.7211.28%
2014ยฃ0.6416.37%
2013ยฃ0.55-67.42%
2012ยฃ1.7084.22%
2011ยฃ0.9262.13%
2010ยฃ0.5780.61%
2009ยฃ0.32-559.63%
2008-ยฃ0.06858-123.16%
2007ยฃ0.30